The inhibition of Kdm4a, resulting in the downregulation of Sqle and subsequent suppression of ROS/JNK/c-Jun signaling pathway, has been clearly elucidated in mouse bladder cancer models as described above. This evidence concerns the gene KDM4A and urinary bladder carcinoma.